ATE107313T1 - Synthetisches pseudomonas aeruginosa pilin-peptid und verwandte impfstoffe und diagnostika. - Google Patents
Synthetisches pseudomonas aeruginosa pilin-peptid und verwandte impfstoffe und diagnostika.Info
- Publication number
- ATE107313T1 ATE107313T1 AT90906800T AT90906800T ATE107313T1 AT E107313 T1 ATE107313 T1 AT E107313T1 AT 90906800 T AT90906800 T AT 90906800T AT 90906800 T AT90906800 T AT 90906800T AT E107313 T1 ATE107313 T1 AT E107313T1
- Authority
- AT
- Austria
- Prior art keywords
- amino acid
- aeruginosa
- diagnostics
- pseudomonas aeruginosa
- immunogens
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 101001059409 Pseudomonas aeruginosa Fimbrial protein Proteins 0.000 title 1
- 101001059435 Pseudomonas aeruginosa Fimbrial protein Proteins 0.000 title 1
- 101000847512 Pseudomonas aeruginosa Fimbrial protein Proteins 0.000 title 1
- 101000932507 Pseudomonas aeruginosa Fimbrial protein Proteins 0.000 title 1
- 101001029902 Pseudomonas aeruginosa Fimbrial protein Proteins 0.000 title 1
- 101001059399 Pseudomonas aeruginosa Fimbrial protein Proteins 0.000 title 1
- 101001063198 Pseudomonas aeruginosa Fimbrial protein Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 125000000539 amino acid group Chemical group 0.000 abstract 4
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 108010000916 Fimbriae Proteins Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34456589A | 1989-04-28 | 1989-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE107313T1 true ATE107313T1 (de) | 1994-07-15 |
Family
ID=23351056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90906800T ATE107313T1 (de) | 1989-04-28 | 1990-04-26 | Synthetisches pseudomonas aeruginosa pilin-peptid und verwandte impfstoffe und diagnostika. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5445818A (de) |
| EP (1) | EP0469045B1 (de) |
| JP (1) | JP2963536B2 (de) |
| AT (1) | ATE107313T1 (de) |
| AU (1) | AU5533490A (de) |
| CA (3) | CA1340530C (de) |
| DE (1) | DE69010001T2 (de) |
| DK (1) | DK0469045T3 (de) |
| WO (1) | WO1990013563A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5494672A (en) * | 1989-04-28 | 1996-02-27 | S.P.I. Synthetic Peptides Incorporated | Pseudomonas peptide composition and method |
| US5223604A (en) * | 1991-06-25 | 1993-06-29 | S.P.I. Synthetic Peptides Incorporated | Pseudomonas exoenzyme s peptide composition and method |
| US6613530B1 (en) | 1994-07-25 | 2003-09-02 | Roche Diagnostics Gmbh | Determination of a specific immunoglobulin using multiple antigens |
| US6872398B2 (en) * | 1995-12-22 | 2005-03-29 | The United States Of America As Represented By The Secretary Of The Army | Conjugate vaccine against gram-negative bacterial infections |
| US6270777B1 (en) * | 1996-12-20 | 2001-08-07 | University Technologies International Inc. | Conserved metalloprotease epitopes |
| US20030054012A1 (en) * | 2000-05-12 | 2003-03-20 | Fitzgerald David J. | Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response |
| DK1000163T3 (da) * | 1997-07-11 | 2006-02-06 | Us Gov Health & Human Serv | Pseudomonas-exotoksin A-lignende kimære immunogener |
| US7314632B1 (en) * | 1997-07-11 | 2008-01-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Pseudomonas exotoxin A-like chimeric immunogens |
| CA2329689A1 (en) * | 1998-06-12 | 1999-12-23 | The Governors Of The University Of Alberta | Composition and method for treatment of pseudomonas |
| US20030228324A1 (en) * | 1999-05-06 | 2003-12-11 | Malcolm Andrew J. | Peptide compositions and methods of producing and using same |
| US6863896B1 (en) * | 1999-10-26 | 2005-03-08 | Chiron Corporation | Plant lectins as mucosal adjuvants |
| ES2322240T3 (es) * | 2000-12-21 | 2009-06-18 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Una proteina quimerica que comprende secuencias de exotoxina a de pseudomonas no toxica y de pilina de tipo iv. |
| US7132101B2 (en) | 2002-02-27 | 2006-11-07 | Duquesne University Of The Holy Ghost | Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
| WO2006041906A2 (en) | 2004-10-04 | 2006-04-20 | Trinity Biosystems, Inc. | Methods and compositions for immunizing against pseudomonas infection |
| WO2007089272A2 (en) | 2005-07-22 | 2007-08-09 | The Regents Of The University Of Colorado, A Body Corporate | Non-toxic biofilm inhibitor |
| WO2011094363A2 (en) | 2010-01-26 | 2011-08-04 | The Regents Of The University Of Colorado | Influenza virus compositions and methods for universal vaccines |
| CN107002119A (zh) | 2014-03-24 | 2017-08-01 | 豪夫迈·罗氏有限公司 | 使用c‑met拮抗剂的癌症治疗及前者与hgf表达的关联 |
| KR20200018483A (ko) | 2017-06-14 | 2020-02-19 | 비로메틱스 아게 | 호흡기 합포체 바이러스에 대한 방어를 위한 고리형 펩티드 |
| AU2019408048A1 (en) | 2018-12-20 | 2021-06-24 | Universität Zürich | Lipopeptide building blocks and synthetic virus-like particles |
| US20230355737A1 (en) | 2020-09-28 | 2023-11-09 | Dbv Technologies | Particle comprising an rsv-f protein for use in rsv vaccination |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0048422A3 (de) * | 1980-09-15 | 1983-08-24 | Bactex Incorporated | Haare von Pseudomonas-Aeruginosa und deren Verwendung als Impfstoffe gegen infektiöse P.Aeruginosa |
| US4443549A (en) * | 1981-10-19 | 1984-04-17 | Molecular Genetics, Inc. | Production of monoclonal antibodies against bacterial adhesins |
| US4886663A (en) * | 1983-01-03 | 1989-12-12 | Scripps Clinic And Research Foundation | Synthetic heat-stable enterotoxin polypeptide of Escherichia coli and multimers thereof |
| DE3465051D1 (en) * | 1983-07-23 | 1987-09-03 | Zahnradfabrik Friedrichshafen | Pressure medium control unit for servo steerings |
| DK219084D0 (da) * | 1984-05-02 | 1984-05-02 | Frederik Carl Peter Lindberg | Antigen |
| CA1256370A (en) * | 1984-02-24 | 1989-06-27 | Yuzuru Homma | Toxoids of elastase of pseudomonas aeruginosa origin |
| US4702911A (en) * | 1985-09-27 | 1987-10-27 | Immunomed Corporation | Preparation of bacterium pili subunits and vaccines containing pili subunits |
| CA1319101C (en) * | 1986-09-03 | 1993-06-15 | Marta Iris Sabara | Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
| JP2635742B2 (ja) * | 1986-12-22 | 1997-07-30 | トリオン、フォルスクニング‐オホ、ウトベクリングス、アクチェボラーグ | 新規ポリペプチド及びその用途 |
| US5494672A (en) * | 1989-04-28 | 1996-02-27 | S.P.I. Synthetic Peptides Incorporated | Pseudomonas peptide composition and method |
-
1989
- 1989-07-12 CA CA000605503A patent/CA1340530C/en not_active Expired - Fee Related
-
1990
- 1990-04-26 DE DE69010001T patent/DE69010001T2/de not_active Expired - Fee Related
- 1990-04-26 WO PCT/CA1990/000135 patent/WO1990013563A1/en active IP Right Grant
- 1990-04-26 JP JP2506533A patent/JP2963536B2/ja not_active Expired - Fee Related
- 1990-04-26 CA CA002053924A patent/CA2053924C/en not_active Expired - Fee Related
- 1990-04-26 DK DK90906800.9T patent/DK0469045T3/da active
- 1990-04-26 AU AU55334/90A patent/AU5533490A/en not_active Abandoned
- 1990-04-26 AT AT90906800T patent/ATE107313T1/de not_active IP Right Cessation
- 1990-04-26 CA CA002443232A patent/CA2443232A1/en not_active Abandoned
- 1990-04-26 EP EP90906800A patent/EP0469045B1/de not_active Expired - Lifetime
-
1992
- 1992-08-10 US US07/927,797 patent/US5445818A/en not_active Expired - Fee Related
-
1995
- 1995-08-25 US US08/519,506 patent/US5612036A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0469045A1 (de) | 1992-02-05 |
| WO1990013563A1 (en) | 1990-11-15 |
| US5445818A (en) | 1995-08-29 |
| JP2963536B2 (ja) | 1999-10-18 |
| DE69010001D1 (de) | 1994-07-21 |
| US5612036A (en) | 1997-03-18 |
| DK0469045T3 (da) | 1994-09-26 |
| AU5533490A (en) | 1990-11-29 |
| CA2443232A1 (en) | 1990-10-29 |
| CA2053924A1 (en) | 1990-10-29 |
| DE69010001T2 (de) | 1994-09-22 |
| CA1340530C (en) | 1999-05-04 |
| EP0469045B1 (de) | 1994-06-15 |
| JPH04504719A (ja) | 1992-08-20 |
| CA2053924C (en) | 2003-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69010001D1 (de) | Synthetisches pseudomonas aeruginosa pilin-peptid und verwandte impfstoffe und diagnostika. | |
| ES2540771T3 (es) | Composición de anticuerpos para uso en vacunación contra estafilococos | |
| KR950702839A (ko) | 레트로, 인버소-, 및 레트로- 인버소 합성 펩티드 유사체(retro-, inverso-, and retro-inverso synthetic peptide analogues) | |
| RU98118184A (ru) | Пептидные иммуногены для вакцинации и лечения аллергии | |
| DE69327587T2 (de) | Konjugate von schwach immunogenen antigenen und synthetischen peptidträgern und impfstoffe diese enthaltend | |
| NO913518L (no) | Vaksiner for ikke typebestembar haemophilus influenzae. | |
| SE7604972L (sv) | Antigeniskt aktiv polypeptid och forfarande for dess framstellning | |
| GR3029264T3 (en) | Anti-feline immunodeficiency virus (fiv) vaccines. | |
| DE69738770D1 (de) | Porphyromonas gingivalis Antigene zur Diagnose und Behandlung von Periodontitis | |
| Hudecz | Manipulation of epitope function by modification of peptide structure: a minireview | |
| KR910000179A (ko) | Aids용 결합체 면역원 | |
| DE59101577D1 (de) | Immunologisch aktive peptide bzw. polypeptide des parvovirus b19. | |
| KR920004422A (ko) | Hiv의 주요 중화 결정인자 | |
| CA2128407A1 (en) | Synthetic peptides for a rubella vaccine | |
| PT87239A (pt) | Process for the preparation of peptides | |
| DK0426314T3 (da) | HIV-relaterede peptider | |
| FR2408581A1 (fr) | Composition de pentapeptide, son procede d'obtention et composition therapeutique en comportant | |
| Lüscher et al. | Induction of immunological tolerance to the penicilloyl antigenic determinant—iv. The effect of BPO-oligolysines and cholestanol-bearing BPO-oligolysines on murine IgE responses | |
| GB2314560A (en) | Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use | |
| FI961398A (fi) | Menetelmä terapeuttisesti käyttökelpoisen peptidin valmistamiseksi | |
| ES2065254A1 (es) | Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |